- UroToday Home
- Recent Abstracts
- Pelvic Health & Reconstruction
Overactive Bladder
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline - Abstract
November 5, 2012
Relationship between body mass index and overactive bladder in women and correlations with urodynamic evaluation - Abstract
November 3, 2012
Acute spinal cord injury: Do ambulatory patients need urodynamic investigations? - Abstract
October 31, 2012
Population pharmacokinetics and exposure-response relationship of a muscarinic receptor antagonist, imidafenacin - Abstract
October 31, 2012
Results of a randomized phase III trial of mirabegron in patients with overactive bladder - Abstract
October 30, 2012
Common theme for drugs effective in overactive bladder treatment: Inhibition of afferent signaling from the bladder - Abstract
October 29, 2012
Comparative persistence and adherence to overactive bladder medications in patients with and without diabetes - Abstract
October 24, 2012
Decreased intravesical ATP in patients with refractory detrusor overactivity and bacteriuria - Abstract
October 23, 2012
MYRBETRIQ™ (mirabegron), overactive bladder treatment from Astellas, now available through U.S. pharmacies
October 22, 2012
Intravesical botulinum type-A toxin (Dysport(®)) in the treatment of idiopathic detrusor overactivity in children - Abstract
October 19, 2012
A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trials - Abstract
October 18, 2012
